To further test the specificity of the ADP-ribosylation, we investigated the effect of ADP-ribose, the Arp2/3-activating WASP-VCA peptide (Wiskott-Aldrich syndrome Verprolin C-terminal acidic peptide), and of F-actin on this reaction. Here, ACTR2 is linked to Wiskott-Aldrich syndrome.